SHWZ

Medicine Man Technologies, Inc.
CAPPED RATING

Medicine Man Technologies, Inc., doing business as Schwazze, operates as a cannabis company. It operates through three segments: Retail, Wholesale, and Other. The company offers cannabis products that include loose flower, concentrates, edibles, pre-rolls, topicals, and other associated cannabis products; and vape cartridges and syringes. As of March 14, 2022, it owned and operated 23 retail cannabis dispensaries under the Star Buds, Smoking Gun Apothecary, Emerald Fields, and Drift banner names in Denver and Colorado; and 10 medical retail cannabis dispensaries under the R. Greenleaf banner in New Mexico. The company also provides licensing and consulting, facility design, and facility management services; and Three A Light publication. In addition, it manufactures, wholesales, and retails various plant nutrients for cannabis; and supplies hydroponics and indoor gardening supplies. The company was incorporated in 2014 and is headquartered in Denver, Colorado.

Medicine Man Technologies, Inc. (SHWZ) is rated C- (1.9/5) on Deltasharpe Prism, scored against General sector peers. Its strongest pillar is Value (C+); its weakest is Momentum (D-). The rating has held at C- for 134 weeks.

Quantitative Factor Evaluation • Updated

Overall Rating
1.9 / 5.0
C-
Value
C+
Factor Score 2.5 / 5.0
Growth
C
Factor Score 2.4 / 5.0
Profitability
C-
Factor Score 1.9 / 5.0
Momentum
D-
Factor Score 0.9 / 5.0
Revisions
D+
Factor Score 1.5 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio N/A
EV / EBITDA N/A
Rev Growth YoY 7.9%
Gross Margin 16.2%
Price Return 3M 0.0%
Price Return 12M -99.5%
Catalyst Signal 0.00
Market Cap N/A
TTM Revenue N/A
Price / Sales N/A
ROE -24.6%

Historical Factor Score Progression

Held C- for 134 weeks
Date Value Growth Profitability Momentum Revisions Overall
2026-07-29 C+ (2.5) C (2.4) C- (1.9) D- (0.9) D+ (1.5) C- (1.9)
2023-12-31 C+ (2.5) C (2.4) D+ (1.8) D+ (1.7) D (1.5) C- (2.0)
2023-09-30 C+ (2.5) C+ (2.5) C+ (2.7) D+ (1.7) D (1.5) C (2.2)
2023-06-30 C+ (2.5) C- (2.0) B- (3.0) D+ (1.7) D (1.5) C- (2.1)
2023-03-31 C+ (2.5) D+ (1.6) B- (3.0) D+ (1.7) D (1.5) C- (2.1)
Page 1 of 2